Research Article
The Kinetics of Anti-HLA Antibodies in the First Year after Kidney Transplantation: In Whom and When Should They Be Monitored?
Table 1
Baseline patient characteristics.
| | PRE-TX groups (N = 150) | Group A | Group B | Group C | | | 89 (59.3%) | 39 (26%) | 22 (14.7%) |
| | Recipient age (y) | 45.1 (±13.5) | 50.5 (±13) | 44 (±10) | 0.066 | | Donor age (y) | 42.7 (±11.5) | 44.1 (±10.5) | 46.7 (±11.3) | 0.313 | | Dialysis pre-TX: yes | 84 (94.4%) | 36 (92.3%) | 22 (100%) | 0.521 | | Gender: male | 64 (71.9%) | 14 (35.1%) | 5 (22.7%) | <0.001 | | Donor: deceased | 54 (60.7%) | 30 (76.9%) | 15 (68.2%) | 0.198 | | First transplant | 86 (96.6%) | 36 (92.3%) | 13 (59.1%) | <0.001 | | Pregnancy: Yes (at least 1) | 14 (56.0%) | 23 (92.0%) | 14 (82.4%) | <0.001 | | Transfusion: Yes (at least 1) | 36 (40.4%) | 22 (56.4%) | 14 (63.6%) | 0.068 | | Mean PRA class I | 0 | 6% | 35% | <0.01 | | Mean PRA class II | 0 | 12% | 34% | <0.01 | | Induction: thymoglobulin | 11 (12.4%) | 12 (30.8%) | 19 (86.4%) | <0.001 |
|
|
PRA: panel reactive antibody.
|
